Ok, here is my question(s) and I discussed this be
Post# of 36537
They just did the framework for the China deal. Not quite sure when this deal will be finalized and signed, but this should actually be a really big deal and should make everyone feel pretty positive overall even if you take the vaccine completely out of the scenario.
My question is this. You have the Chinese partner wanting the whole package - the Covid Vaccine, AE37, Excellagen. I'm surprised they didn't ask for the diabetes part as well, but that's another story. Anyways, AE37 has 10 years now of positive history behind it. So, they can run complete trials now in China with this partner for AE37 and get the approval I would suspect, and then bring back results as well to show here in America?
Concerning Excellagen, since they have the framework for the deal and it looks like this is happening, any thoughts if they are already producing Excellagen to send to China? Since they already have the product and it's been available for the VA hospitals here, they are not reinventing the wheel. This is an easy process for Generex to start turning a profit on with their Chinese partner I would think once the deal is signed to deliver Excellagen. Not quite sure what the actual shelf life is though.
Now, we only need to hear about NGIO and the time for listing...